Clinical Trial Update: Study of Vosaroxin and Decitabine in Older Patients With Acute Myeloid Leukemia and High-risk Myelodysplastic Syndrome [Phase 1, Phase 2]

View source ↗

Summary

A phase 1/2 trial evaluating vosaroxin with decitabine in older adults with acute myeloid leukemia and high-risk myelodysplastic syndrome has completed; results…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia
• Myelodysplastic Syndrome

Drugs mentioned

• Decitabine (Decitabine)
• Vosaroxin (vosaroxin)

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Leukemia | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2022-02-09